Fairfax Financial Holdings - STRONGBRIDGE BIOPHARMA PLC ownership

Quarter-by-quarter ownership
Fairfax Financial Holdings ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$392,000
-31.5%
193,1070.0%0.01%
-27.8%
Q2 2021$572,000193,1070.02%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders